Tavros was founded with a mission to discover novel targeted cancer therapies using cutting edge genomics technologies to improve outcomes for cancer patients.

Tavros’ team is comprised of talented scientists and leaders with the scientific, discovery and development expertise to advance potential therapies to improve outcomes for cancer patients.

Amanda McCune

Sr. Research Associate

Ashley Suchy

Research Associate

Claire Atkinson


Demi Sotomayor

Business Operations Manager

Elisebeth Toretti

Sr. Research Associate

Eoin McDonnell

CEO, Co-founder, Board Member

Hannah Willis

Research Associate II

Jake Hoj

Sr. Scientist

Jeff Warrington

Computational Chemist

Kaela Farno

Research Associate

Kris Wood

Co-founder, Board Member

Assoc. Professor, Duke University
Lilly Wong

Research Associate II

Nikki Heron


Niranjan Venkateswaran


Ralph Rivero

Head of Chemistry, Target 2

Rediet Oshone

Sr. Scientist

Risigan Logendran

Lab Operations Manager

Robert Baldi

Sr. Research Associate

Robert Long

Board Member

Co-founder Piedmont Capital Investments
Sunghee Park

Principal Scientist

Thomas Bass

Sr. Scientist

Tony Sun

Strategic Advisor

Warren Wade

Head of Chemistry, Target X

Zach Carico

Sr. Scientist

Interested in joining our team?